Filing Details
- Accession Number:
- 0001305773-18-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-30 21:25:21
- Reporting Period:
- 2018-04-26
- Accepted Time:
- 2018-04-30 21:25:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1305773 | Conformis Inc | CFMS | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1403401 | Bradley Langdale | C/O Conformis, Inc. 600 Technology Park Drive Billerica MA 01821 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-04-26 | 75,764 | $1.40 | 102,297 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-04-26 | 75,764 | $1.52 | 26,533 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2018-04-27 | 4,236 | $1.40 | 30,769 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2018-04-26 | 75,764 | $0.00 | 75,764 | $1.40 |
Common Stock | Stock Option (right to buy) | Disposition | 2018-04-27 | 4,236 | $0.00 | 4,236 | $1.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,236 | 2018-05-28 | No | 4 | M | Direct | |
0 | 2018-05-28 | No | 4 | M | Direct |
Footnotes
- This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
- The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.47-$1.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- This option is fully vested.